Lumiliximab (Anti-FceR2 / CD23)Lumiliximab (Anti-FceR2 / CD23)
Move your mouse over image or click to enlarge

Lumiliximab (Anti-FceR2 / CD23)

Lumiliximab (Anti-FceR2 / CD23) is a monoclonal antibody targeting CD23, that inhibits allergen-induced responses. MW: 145.5 KD.
Cat# Size Price Qty Buy
A2501-1mg*25 1mg*25
£1,941.00
A2501-1mg*5 1mg*5
£647.00
A2501-1mg 1mg
£221.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2501

Related Documents